Pfizer’s Mylotarg is back ... after the FDA reapproved it in the aggressive blood cancer, acute myeloid leukaemia. The world’s first approved antibody-drug conjugate, where a targeted antibody ...

The U.S. Food and Drug Administration has approved ... with hemophilia because it can be administered less frequently than other existing options,” said Tanya Wroblewski, M.D., deputy director of the ...

WASHINGTON, D.C. — The U.S. Food and Drug ... FDA’s approval of Qfitlia was based on findings from two large multicenter, randomized clinical trials involving 177 male patients with hemophilia ...

"Today's approval ... in the FDA's Center for Drug Evaluation and Research. "This new treatment option highlights our continued efforts to improve the lives of patients with hemophilia." ...